SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-15-009380
Filing Date
2015-02-17
Accepted
2015-02-17 07:53:29
Documents
2
Group Members
NQ HCIF GENERAL PARTNER, L.P.NQ HCIF GP, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v401665_sc13g.htm SC 13G 78507
2 EXHIBIT 99.1 v401665_ex99-1.htm EX-99.1 6823
  Complete submission text file 0001144204-15-009380.txt   87134
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88023 | Film No.: 15617939
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609 919-459-8620
NovaQuest Pharma Opportunities Fund III, L.P. (Filed by) CIK: 0001506260 (see all company filings)

IRS No.: 800647974 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G